Stone, KidneyNCT06579924
Disposable Versus Disposable Nephroscope During PCNLs: a Feasibility RCT
A study testing Disposable mini-PCNL and Re-usable mini-PCNL in people with Stone, Kidney, run by The First Affiliated Hospital of Guangzhou Medical University at 1 site in China.
Trial summary
A feasibility randomised controlled trials comparing re-usable versus disposable nephroscope when treating kidney stones during mini-PCNLs Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Stone, Kidney
- What is being tested?
- Disposable mini-PCNL and Re-usable mini-PCNL
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteChina
- Study dates
- 1 Sep 2024to 30 Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients undergoing mini PCNL to treat renal stones with a cumulative stone diameter 2-5 cm and completing at least a 3 month's follow-up
- Cases performed by surgeons beyond their learning curves
- Patients aged > 18
- Unenhanced CT scan carried out within 3 months pre-operatively
- Post-operative follow-up carried out according to our study protocol, with NCCT carried out within 2-3 months after surgery
- ASA 1-2
Show all 18Show fewer
- Patients with normal weight (BMI: 18-25)
- Participant is willing and able to give informed consent to the proposed surgical treatment and agreeing to be enrolled in the study.
- Exclusion Criteria:• Contraindications to surgical treatment
- PCNL performed for proximal ureteric stones
- Urinary tract with abnormal anatomy
- Obese patients
- ASA>3
- Patients with pyonephrosis
- Patients on anticoaugulants
- Preoperative CT scan not within 3 months before surgery
- Pregnant patients
- Patients younger than 18 years of age
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
China1 site
Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510230
About this study
Official title: Re-usable Versus Disposable Rigid Nephroscope During Mini-PCNLs When Treating Large-burden Kidney Stones: an Feasibility Randomised Controlled Trial
A feasibility randomised controlled trials comparing re-usable versus disposable nephroscope when treating kidney stones during mini-PCNLs
Read the detailed description
Study Participants Patients undergoing minimally-invasive PCNLs with intention to treat renal low- to medium-burden renal stones.
Inclusion Criteria
- Patients undergoing mini PCNL to treat renal stones with a cumulative stone diameter 2-5 cm and completing at least a 3 month's follow-up
- Cases performed by surgeons beyond their learning curves
- Patients aged \> 18
- Unenhanced CT scan carried out within 3 months pre-operatively
- Post-operative follow-up carried out according to our study protocol, with NCCT carried out within 2-3 months after surgery
- ASA 1-2
- Patients with normal weight (BMI: 18-25)
- Participant is willing and able to give informed consent to the proposed surgical treatment and agreeing to be enrolled in the study.
Exclusion Criteria
The participant may not enter the study if ANY of the following apply:
- Contraindications to surgical treatment
- PCNL performed for proximal ureteric stones
- Urinary tract with abnormal anatomy
- Obese patients
- ASA\>3
- Patients with pyonephrosis
- Patients on anticoaugulants
- Preoperative CT scan not within 3 months before surgery
- Pregnant patients
- Patients younger than 18 years of age Study design and pathway The study will include patients with renal stones and undergoing mini-PCNL. All patients should respect inclusion/exclusion criteria. An ultra-low dose unenhanced CT scan (NCCT) has to be available for all cases pre-operatively, the post-operative follow-up will include NCCT within 2-3 months from treatment.
Patients will complete the study at 3 months post-op when the stone free rate will be assessed. Additionally, 30 days post-op complications will be recorded using Clavien-Dindo system. 3 months post-op stone-related events will be also registered.
Prior to enroll patients, participating surgeons will be asked to carry out 5 mini-PCNLs with disposable scope, aiming to render them more familiar and achieve learning curve.
Once the RCT will start, patient will be randomized in two groups using computer software (disposable group arm and non-disposable group arm).
Peri-operative data collection Peri-operative data will be collected using a standardized excel database produced by main investigator site.
The Stone complexity will be calculated according to database. Each case should be evaluated by two experienced surgeons and appropriate scoring should be agreed.
30 days post-operative complications should be recorded and reported using Clavien-Dindo classification System in its modified version for PCNLs. Type of complication in each Centre should be agreed by two different surgeons.
Post-operative patients' quality of life will be evaluated using validated version of WISQoL in Chinese7. It will be measured at 24 hours and 7 days post-op.
Definition of Stone free State: no \> or equal to 2mm residual fragments (measured with post-operative NCCT). Size of residual fragments should be agreed with radiologist.
PCNL-Trifecta achievement will also be recorded.
Stone burden measurement
Authors will report maximum stone diameter and stone complexity reported using Guy's8 and S.T.O.N.E. nephrolithometry Score9. Stone characteristics should be agreed by two different surgeons. If multiple stones are present, the sum of their volume should be reported.
Surgical technique
Patients deemed suitable and enrolled in the study, will be operated as per routinary technique. This will include a prone position and placement of a retrograde 5-6 Fr ureteric catheter for pyelogram and dilatation of the urinary tract.
The puncture will be carried out according to surgeon's preference (under ultrasound, fluoroscopy or combination).
The track preparation will be carried out with one-shot dilator, if necessary progressive dilatation can be conducted. The percutaneous sheath will be 18 Fr.
The Single-Use Video Cystoscope RP-U-C0102 without bendable tip produced by (Redpine) will be used as rigid nephroscope in disposable group arm. This device has already obtained approval for endoluminal surgeries in China as well as CE and FDA approval for utilization in Western countries. In the non-disposable group, an equivalent size Hawk nephroscope will be used in the non-disposable arm.
The lithotripsy will be done with Ho-YAG laser, using a 550-micron laser fiber or ballistic lithotripter is believed appropriate.
In both arms, the percutaneous sheath will be 18 Fr peel-away sheath. Cases can be conducted tubeless or totally tubeless if necessary. If believed appropriate, in the group of patients treated with disposable cystoscope, surgeons are allowed to switch to a reusable nephroscope for any reason (which will be documented).
Definition of investigated complications
Complications will be categorized using Clavien-Dindo system. Authors will also specifically investigate bleeding and infective complications.
Infectious complications will include:
- Infection will be defined as temperature above 38C for a minimum of 24 hours and/or procalcitonin \> 0,5 ng/mL and/or reactive C protein \> 10.
- Septic shock: diagnosed using qSOFA Score
- ICU admission for sepsis
- Death
- Perirenal abscess
Hemorragic complications will include:
- Transfusion
- Hemoglobin drop \>2 gr/dL
- Angioembolization
- Bleeding requiring secondary operation (bladder washout, ureteric stent positioning)
- Emergency nephrectomy for uncontrollable bleeding
- Hypovolemic shock requiring ICU stay
Study population
A total of 100 procedures will be included. The study will involve three surgeons. Each surgeon will carry out 20 procedures, 10 for each arm. The numerosity has been arbitrarily decided and in line with characteristics of pilot studies, aiming to test feasibility of disposable PCNLs and estimate numerosity for future RCT on this topic Before enrolling patients, all participating surgeons will be asked to carry out 5 mini-PCNLs with disposable scopes to render them familiar with the procedure and adjust the learning curve.
Statistical analysis The Statistical Package for the Social Sciences (SPSS) 20 will be used for statistical analysis.
Continuous variables will be presented as means (SDs) in cases of normal distribution and compared using the independent Student's t-test, while as median and interquartile range (IQR) in cases of skewed distributions and compared using the Mann-Whitney U-test. Categorical variables will be presented as numbers with percentages and compared using chi-square or Fisher's exact tests. Statistical significance will be considered for two-tailed P values of \<0.05.
Endpoints As primary endpoints, authors will evaluate adequacy of disposable scopes (evaluating need to switch to re-usable scopes due to breakages, inadequacy, failures) and Stone Free Rates.
Authors will also collect as secondary endpoints complication rates and patients comfort, using WISQoL questionnaires.
Additionally, authors will use Likert scales to evaluate surgeons' appreciation (view, handling and weight of the instruments, irrigation, stability of the instrument, position and functionality of working channels).
Authors will also monitor the number procedures where there will be need of switching to re-usable scopes (due to malfunctioning/breakage/inadequacy of disposable scopes).
- Conditions
- Stone, Kidney
- Being tested
- Disposable mini-PCNL, Re-usable mini-PCNL
- Medical subject headings
- Kidney Calculi
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Disposable mini-PCNLProcedure or surgery
Mini-PCNL carried out using disposable scope
Re-usable mini-PCNLProcedure or surgery
Mini-PCNL carried out using re-usable scope
| Study group | Role | What they receive |
|---|---|---|
| Mini-PCNL with disposable scope | Experimental | PCNLs carried out using disposable scope Receives: Procedure: Disposable mini-PCNL |
| Mini-PCNL using re-usable scope | Active comparator | Mini-PCNLs carried out using re-usable scope Receives: Procedure: Re-usable mini-PCNL |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stone free rate
ability of used scope in determining a complete stone clearance, or absence of clinically significant residual fragments
Measured: 90 days post-op
Secondary outcomes (2)
complication rate
presence of post-operative complications according to Calvin-Dindo classification system
Measured: 30 days post-op
adequacy of used instrument
adequacy of instruments (including failure, quality of view, handling) will be tested
Measured: intra-operative assessment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Aug 2024
- Study start1 Sep 2024 (estimated)
- Primary completion30 Mar 2025 (estimated)
- Study completion30 Apr 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stone, KidneyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Guohua Zeng, The First Affiliated Hospital of Guangzhou Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06579924
- Sponsor's protocol ID
- DisposableRCTStudy
- Status last verified
- Aug 2024
- First submitted
- 11 Aug 2024
- Last updated
- 30 Aug 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Re-usable Versus Disposable Rigid Nephroscope During Mini-PCNLs When Treating Large-burden Kidney Stones: an Feasibility Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT06579924
- Acronym / sponsor ID
- DisposableRCTStudy
- Conditions
- Stone, Kidney
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- The First Affiliated Hospital of Guangzhou Medical UniversityUniversity, hospital or other
- Study start
- 1 Sep 2024 (estimated)
- Primary completion
- 30 Mar 2025 (estimated)
- Study completion
- 30 Apr 2025 (estimated)
- First posted
- 30 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A feasibility randomised controlled trials comparing re-usable versus disposable nephroscope when treating kidney stones during mini-PCNLs
Detailed description
Study Participants Patients undergoing minimally-invasive PCNLs with intention to treat renal low- to medium-burden renal stones.
Inclusion Criteria
- Patients undergoing mini PCNL to treat renal stones with a cumulative stone diameter 2-5 cm and completing at least a 3 month's follow-up
- Cases performed by surgeons beyond their learning curves
- Patients aged \> 18
- Unenhanced CT scan carried out within 3 months pre-operatively
- Post-operative follow-up carried out according to our study protocol, with NCCT carried out within 2-3 months after surgery
- ASA 1-2
- Patients with normal weight (BMI: 18-25)
- Participant is willing and able to give informed consent to the proposed surgical treatment and agreeing to be enrolled in the study.
Exclusion Criteria
The participant may not enter the study if ANY of the following apply:
- Contraindications to surgical treatment
- PCNL performed for proximal ureteric stones
- Urinary tract with abnormal anatomy
- Obese patients
- ASA\>3
- Patients with pyonephrosis
- Patients on anticoaugulants
- Preoperative CT scan not within 3 months before surgery
- Pregnant patients
- Patients younger than 18 years of age Study design and pathway The study will include patients with renal stones and undergoing mini-PCNL. All patients should respect inclusion/exclusion criteria. An ultra-low dose unenhanced CT scan (NCCT) has to be available for all cases pre-operatively, the post-operative follow-up will include NCCT within 2-3 months from treatment.
Patients will complete the study at 3 months post-op when the stone free rate will be assessed. Additionally, 30 days post-op complications will be recorded using Clavien-Dindo system. 3 months post-op stone-related events will be also registered.
Prior to enroll patients, participating surgeons will be asked to carry out 5 mini-PCNLs with disposable scope, aiming to render them more familiar and achieve learning curve.
Once the RCT will start, patient will be randomized in two groups using computer software (disposable group arm and non-disposable group arm).
Peri-operative data collection Peri-operative data will be collected using a standardized excel database produced by main investigator site.
The Stone complexity will be calculated according to database. Each case should be evaluated by two experienced surgeons and appropriate scoring should be agreed.
30 days post-operative complications should be recorded and reported using Clavien-Dindo classification System in its modified version for PCNLs. Type of complication in each Centre should be agreed by two different surgeons.
Post-operative patients' quality of life will be evaluated using validated version of WISQoL in Chinese7. It will be measured at 24 hours and 7 days post-op.
Definition of Stone free State: no \> or equal to 2mm residual fragments (measured with post-operative NCCT). Size of residual fragments should be agreed with radiologist.
PCNL-Trifecta achievement will also be recorded.
Stone burden measurement
Authors will report maximum stone diameter and stone complexity reported using Guy's8 and S.T.O.N.E. nephrolithometry Score9. Stone characteristics should be agreed by two different surgeons. If multiple stones are present, the sum of their volume should be reported.
Surgical technique
Patients deemed suitable and enrolled in the study, will be operated as per routinary technique. This will include a prone position and placement of a retrograde 5-6 Fr ureteric catheter for pyelogram and dilatation of the urinary tract.
The puncture will be carried out according to surgeon's preference (under ultrasound, fluoroscopy or combination).
The track preparation will be carried out with one-shot dilator, if necessary progressive dilatation can be conducted. The percutaneous sheath will be 18 Fr.
The Single-Use Video Cystoscope RP-U-C0102 without bendable tip produced by (Redpine) will be used as rigid nephroscope in disposable group arm. This device has already obtained approval for endoluminal surgeries in China as well as CE and FDA approval for utilization in Western countries. In the non-disposable group, an equivalent size Hawk nephroscope will be used in the non-disposable arm.
The lithotripsy will be done with Ho-YAG laser, using a 550-micron laser fiber or ballistic lithotripter is believed appropriate.
In both arms, the percutaneous sheath will be 18 Fr peel-away sheath. Cases can be conducted tubeless or totally tubeless if necessary. If believed appropriate, in the group of patients treated with disposable cystoscope, surgeons are allowed to switch to a reusable nephroscope for any reason (which will be documented).
Definition of investigated complications
Complications will be categorized using Clavien-Dindo system. Authors will also specifically investigate bleeding and infective complications.
Infectious complications will include:
- Infection will be defined as temperature above 38C for a minimum of 24 hours and/or procalcitonin \> 0,5 ng/mL and/or reactive C protein \> 10.
- Septic shock: diagnosed using qSOFA Score
- ICU admission for sepsis
- Death
- Perirenal abscess
Hemorragic complications will include:
- Transfusion
- Hemoglobin drop \>2 gr/dL
- Angioembolization
- Bleeding requiring secondary operation (bladder washout, ureteric stent positioning)
- Emergency nephrectomy for uncontrollable bleeding
- Hypovolemic shock requiring ICU stay
Study population
A total of 100 procedures will be included. The study will involve three surgeons. Each surgeon will carry out 20 procedures, 10 for each arm. The numerosity has been arbitrarily decided and in line with characteristics of pilot studies, aiming to test feasibility of disposable PCNLs and estimate numerosity for future RCT on this topic Before enrolling patients, all participating surgeons will be asked to carry out 5 mini-PCNLs with disposable scopes to render them familiar with the procedure and adjust the learning curve.
Statistical analysis The Statistical Package for the Social Sciences (SPSS) 20 will be used for statistical analysis.
Continuous variables will be presented as means (SDs) in cases of normal distribution and compared using the independent Student's t-test, while as median and interquartile range (IQR) in cases of skewed distributions and compared using the Mann-Whitney U-test. Categorical variables will be presented as numbers with percentages and compared using chi-square or Fisher's exact tests. Statistical significance will be considered for two-tailed P values of \<0.05.
Endpoints As primary endpoints, authors will evaluate adequacy of disposable scopes (evaluating need to switch to re-usable scopes due to breakages, inadequacy, failures) and Stone Free Rates.
Authors will also collect as secondary endpoints complication rates and patients comfort, using WISQoL questionnaires.
Additionally, authors will use Likert scales to evaluate surgeons' appreciation (view, handling and weight of the instruments, irrigation, stability of the instrument, position and functionality of working channels).
Authors will also monitor the number procedures where there will be need of switching to re-usable scopes (due to malfunctioning/breakage/inadequacy of disposable scopes).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mini-PCNL with disposable scope | Experimental | Procedure: Disposable mini-PCNLPCNLs carried out using disposable scope |
| Mini-PCNL using re-usable scope | Active comparator | Procedure: Re-usable mini-PCNLMini-PCNLs carried out using re-usable scope |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (18 listed)
- Patients undergoing mini PCNL to treat renal stones with a cumulative stone diameter 2-5 cm and completing at least a 3 month's follow-up
- Cases performed by surgeons beyond their learning curves
- Patients aged > 18
- Unenhanced CT scan carried out within 3 months pre-operatively
- Post-operative follow-up carried out according to our study protocol, with NCCT carried out within 2-3 months after surgery
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Disposable mini-PCNLMini-PCNL carried out using disposable scope | Procedure or surgery | Mini-PCNL with disposable scope |
| Re-usable mini-PCNLMini-PCNL carried out using re-usable scope | Procedure or surgery | Mini-PCNL using re-usable scope |
Primary outcome
Stone free rate
Time frame: 90 days post-op
ability of used scope in determining a complete stone clearance, or absence of clinically significant residual fragments
2 secondary outcomes
complication rate
Time frame: 30 days post-op
adequacy of used instrument
Time frame: intra-operative assessment
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Aug 2024.
- Individual participant dataSharing planned: No
Related trials for Stone, Kidney
RecruitingPhase 1/2
Dexamethasone for Ureteral STent Symptoms (DUSTS)
Ureteral Stent-Related Symptom
Not yet recruitingEarly Phase 1
Phosphate & Kidney Stones
Kidney Stones, Calcium Oxalate Kidney Stones
Recruiting
Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology
Urolithiasis, Stones, Kidney
Active, not recruitingObservational study
A Retrospective, Multi-center Real-world Study of Steerable Ureteroscopic Renal Evacuation (SURE) Procedure With the CVAC® System
Urolithiasis, Kidney Stone
Recruiting
Supervised Endoscopic Tele-controlled Intelligent Lithotripsy
Renal Stone
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Disposable mini-PCNL and Re-usable mini-PCNL in people with Stone, Kidney, run by The First Affiliated Hospital of Guangzhou Medical University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 18 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stone free rate (time frame: 90 days post-op). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2024.